All Stories

  1. The genetic landscape of autosomal dominant polycystic kidney disease in Kuwait
  2. Impact of COVID-19 infection on the dialysis population prospective, observational, nationwide study
  3. Diabetes Prevalence, Treatment, Control, and Outcomes Among Hemodialysis Patients in the Gulf Cooperation Council Countries
  4. Response to and outcomes of the Pfizer BNT162B2 vaccine in hemodialysis patients—A prospective observational study
  5. Use of Rituximab as an Off-Label Medication in Glomerular Diseases: Clinical Perspective
  6. Safety of Intravenous Iron in CKD Stage 3-5 Patients Not on Dialysis: A Retrospective Cohort Study
  7. Global Dialysis Perspective: Kuwait
  8. Current Status and Future of End-Stage Kidney Disease in Gulf Cooperation Council Countries: Challenges and Opportunities
  9. Parathyroid Hormone Serum Levels and Mortality among Hemodialysis Patients in the Gulf Cooperation Council Countries: Results from the DOPPS (2012–2018)
  10. P1532PARATHYROID HORMONE SERUM LEVELS AND MORTALITY AMONG HEMODIALYSIS PATIENTS IN THE GULF COOPERATION COUNCIL COUNTRIES: RESULTS FROM THE DOPPS (2012-2018)
  11. Glomerulonephritis Histopathological Pattern Change
  12. SAT-097 SAFETY OF IV IRON IN CHRONIC KIDNEY DISEASE PATIENTS (STAGES 3-5 ND) IN KUWAIT
  13. SAT-379 Glomerulonephritis Histopathological Pattern Change
  14. Kt/V: achievement, predictors and relationship to mortality in hemodialysis patients in the Gulf Cooperation Council countries: results from DOPPS (2012–18)
  15. Renal Data from the Arab World Dialysis in Kuwait: 2013-2019
  16. SAT-044 THE USE OF TUNNELLED CATHETERS FOR CHRONIC HEMODIALYSIS PATIENTS IN KUWAIT
  17. FP530KT/V ACHIEVEMENT AND SURVIVAL IN HEMODIALYSIS PATIENTS IN THE GULF COOPERATION COUNCIL (GCC) COUNTRIES: INTERNATIONAL RESULTS FROM DOPPS 5 & 6 (2012-2018)
  18. SP197RITUXIMAB USE FOR GLOMERULAR DISORDERS IN KUWAIT
  19. PKD1 Duplicated regions limit clinical Utility of Whole Exome Sequencing for Genetic Diagnosis of Autosomal Dominant Polycystic Kidney Disease
  20. SP587DEMOGRAPHICS AND KEY CLINICAL CHARACTERISTICS OF HEMODIALYSIS PATIENTS FROM THE GULF COOPERATION COUNCIL (GCC) PARTICIPATING IN DOPPS
  21. Basic description of the dialysis population of Kuwait: The 2015 data
  22. Demographics and key clinical characteristics of hemodialysis patients from the Gulf Cooperation Council countries enrolled in the dialysis outcomes and practice patterns study phase 5 (2012-2015)
  23. Evaluation of associations between single nucleotide polymorphisms in the FRMD3 and CARS genes and diabetic nephropathy in a Kuwaiti population
  24. Mineral bone disorder and its management among hemodialysis patients in the Gulf Cooperation Council: Initial findings from the dialysis outcomes and practice patterns study (2012-2015)
  25. Adaptation and Implementation of the "Kidney Disease: Improving Global Outcomes (KDIGO)" Guidelines for Evaluation and Management of Mineral and Bone Disorders in Chronic Kidney Disease for Practice in the Middle East Countries
  26. Cinacalcet Hydrochloride Therapy for Secondary Hyperparathyroidism in Hemodialysis Patients
  27. Intravenous Alfacalcidol Once Weekly Pulse Therapy for Secondary Hyperparathyroidism in Hemodialysis Patients
  28. Renal biopsy in patients with type 2 diabetes mellitus: indications and nature of the lesions
  29. N-acetylcysteine reduces urinary albumin excretion following contrast administration: evidence of biological effect
  30. A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: Lack of effect
  31. Collapsing glomerulopathy coexisting with membranous glomerulonephritis in native kidney biopsies: a report of 3 HIV-negative patients
  32. Isolated renal giant cell arteritis